Dr. Rohit Mody, MD, DM, FACC, FESC, FSCAI, FAPSIC, FRSM, FCSI, is an internationally recognized interventional cardiologist and healthcare leader, currently serving as CEO of Mody Harvard Institutes & Research Centres, Senior Director of Cardiovascular Sciences at Park Hospital Bathinda, and Chairman & Chief of Cardiovascular Sciences at ClearMedi Group of Hospitals (Pan India). He is dedicated to advancing precision cardiovascular care by integrating cutting-edge technology, artificial intelligence–enabled diagnostics, and complex interventional therapies to improve patient outcomes, particularly in resource-limited and emerging healthcare environments, distinguishing himself through his commitment to translating advanced science into accessible real-world clinical practice. Dr. Mody has authored and co-authored more than 104 scientific publications in reputed peer-reviewed journals, delivered numerous invited lectures and case presentations at major international conferences including TCT, CRT, EuroPCR, ICI, and TCTAP, and holds prestigious fellowships from leading global cardiovascular societies such as the American College of Cardiology (FACC), European Society of Cardiology (FESC), and Society for Cardiovascular Angiography and Interventions (FSCAI). His academic influence spans complex coronary interventions, vulnerable plaque biology, precision PCI, calcium modification strategies, structural heart interventions, and cardiogenic shock management, with ongoing participation in major international registries and trials such as TUXEDO-2, iCaReMe Registry, SHOCK India Registry, TRANSEVER Registry and DEFINE-DM. In addition to his research publications, Dr. Mody has actively contributed to academic journals as a peer reviewer for over 40 manuscripts and serves on multiple editorial boards, while also participating as an abstract grader and reviewer for international organizations including the American College of Cardiology (ACC), American Heart Association (AHA), and AsiaPCR platforms. His long-term professional vision focuses on redefining coronary artery disease through the Atherosclerotic Coronary Artery Disease (ACAD) paradigm, emphasizing early detection, plaque biology-guided therapy, artificial intelligence–driven risk prediction, regenerative cardiology, and longevity science, with the ultimate goal of preventing myocardial infarction rather than merely treating its consequences. Dr. Mody is widely recognized for his distinctive professional skills, including strong leadership and team-building abilities, advanced communication and interpersonal competence, effective mentoring of young cardiologists, strategic management of large cardiovascular programs, and exceptional problem-solving skills in complex high-risk clinical scenarios such as left main disease, chronic total occlusions, cardiogenic shock, and structural heart interventions; his active listening approach and patient-centric philosophy further enhance collaborative clinical decision-making and multidisciplinary care delivery. Beyond his professional commitments, he enjoys academic writing, mentoring emerging clinicians, participating in global scientific discussions, exploring innovations in medical technology and longevity science, and engaging in motivational and leadership activities that inspire healthcare professionals and teams.